It has been found that BAK can increase serum ALT, TBIL, and TBA and reduce CYP7a1, HMG-CoA, PPARα, and SREBP-2 mRNA expression, resulting in cholestasis hepatotoxicity. This evidence concerns the gene BAK1 and cholestasis.